{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T09:23:36Z","timestamp":1770542616443,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Education, Culture, Sports, Science and Technology-Japan and the Japan Agency of Medical Research Development","award":["JP 17 km0105001"],"award-info":[{"award-number":["JP 17 km0105001"]}]},{"name":"Ministry of Education, Culture, Sports, Science and Technology-Japan and the Japan Agency of Medical Research Development","award":["JP 21tm0124005"],"award-info":[{"award-number":["JP 21tm0124005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12282-022-01404-7","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T05:03:37Z","timestamp":1664168617000},"page":"110-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Returning individual genomic results to population-based cohort study participants with BRCA1\/2 pathogenic variants"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6919-6529","authenticated-orcid":false,"given":"Kinuko","family":"Ohneda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Hamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kawame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Fuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuji","family":"Nagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Yamaguchi-Kabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"JC Denny","year":"2019","unstructured":"Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, Jenkins G, et al. The \u201call of us\u201d research program. N Engl J Med. 2019;381:668\u201376. https:\/\/doi.org\/10.1056\/NEJMsr1809937.","journal-title":"N Engl J Med"},{"key":"1404_CR2","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41436-020-0905-3","volume":"22","author":"C Hoell","year":"2020","unstructured":"Hoell C, Wynn J, Rasmussen LV, Marsolo K, Aufox SA, Chung WK, et al. Participant choices for return of genomic results in the eMERGE network. Genet Med. 2020;22:1821\u20139. https:\/\/doi.org\/10.1038\/s41436-020-0905-3.","journal-title":"Genet Med"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.gim.2022.01.015","volume":"24","author":"KA Leppig","year":"2022","unstructured":"Leppig KA, Kulchak Rahm A, Appelbaum P, Aufox S, Bland ST, Buchanan A, et al. The reckoning: the return of genomic results to 1444 participants across the eMERGE3 network. Genet Med. 2022;24:1130\u20138. https:\/\/doi.org\/10.1016\/j.gim.2022.01.015.","journal-title":"Genet Med"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00439-020-02207-6","volume":"140","author":"Y Horiuchi","year":"2021","unstructured":"Horiuchi Y, Matsubayashi H, Kiyozumi Y, Nishimura S, Higashigawa S, Kado N, et al. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients. Hum Genet. 2021;140:321\u201331. https:\/\/doi.org\/10.1007\/s00439-020-02207-6.","journal-title":"Hum Genet"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ajhg.2018.07.009","volume":"103","author":"MLB Schwartz","year":"2018","unstructured":"Schwartz MLB, McCormick CZ, Lazzeri AL, Lindbuchler DM, Hallquist MLG, Manickam K, et al. A model for genome-first care: returning secondary genomic findings to participants and their healthcare providers in a large research cohort. Am J Hum Genet. 2018;103:328\u201337. https:\/\/doi.org\/10.1016\/j.ajhg.2018.07.009.","journal-title":"Am J Hum Genet"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41431-020-00760-2","volume":"29","author":"L Leitsalu","year":"2021","unstructured":"Leitsalu L, Palover M, Sikka TT, Reigo A, Kals M, P\u00e4rn K, et al. Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants. Eur J Hum Genet. 2021;29:471\u201381. https:\/\/doi.org\/10.1038\/s41431-020-00760-2.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/gim.2017.145","volume":"20","author":"AH Buchanan","year":"2018","unstructured":"Buchanan AH, Manickam K, Meyer MN, Wagner JK, Hallquist MLG, Williams JL, et al. Early cancer diagnoses through BRCA1\/2 screening of unselected adult biobank participants. Genet Med. 2018;20:554\u20138. https:\/\/doi.org\/10.1038\/gim.2017.145.","journal-title":"Genet Med"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s12282-020-01148-2","volume":"28","author":"R Yoshida","year":"2021","unstructured":"Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2021;28:1167\u201380. https:\/\/doi.org\/10.1007\/s12282-020-01148-2.","journal-title":"Breast Cancer"},{"key":"1404_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3748\/wjg.v23.i6.935","volume":"23","author":"H Matsubayashi","year":"2017","unstructured":"Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, et al. Familial pancreatic cancer: concept, management and issues. World J Gastroenterol. 2017;23:935\u201348. https:\/\/doi.org\/10.3748\/wjg.v23.i6.935.","journal-title":"World J Gastroenterol"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jamaoncol.2020.2134","volume":"6","author":"V Silvestri","year":"2020","unstructured":"Silvestri V, Leslie G, Barnes DR, CIMBA Group, Agnarsson BA, Aittom\u00e4ki K, et al. Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants: results from the consortium of investigators of modifiers of BRCA1\/2 (CIMBA). JAMA Oncol. 2020;6:1218\u201330. https:\/\/doi.org\/10.1001\/jamaoncol.2020.2134.","journal-title":"JAMA Oncol"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","volume":"8","author":"Y Momozawa","year":"2022","unstructured":"Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y, et al. Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants. JAMA Oncol. 2022;8:871\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2022.0476.","journal-title":"JAMA Oncol"},{"key":"1404_CR12","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004;95:866\u201371. https:\/\/doi.org\/10.1111\/j.1349-7006.2004.tb02195.x.","journal-title":"Cancer Sci"},{"key":"1404_CR13","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1002\/cncr.31307","volume":"124","author":"AA Turk","year":"2018","unstructured":"Turk AA, Wisinski KB. PARP inhibitors in breast cancer: bringing synthetic lethality to the bedside. Cancer. 2018;124:2498\u2013506. https:\/\/doi.org\/10.1002\/cncr.31307.","journal-title":"Cancer"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565\u201374. https:\/\/doi.org\/10.1038\/gim.2013.73.","journal-title":"Genet Med"},{"key":"1404_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","volume":"19","author":"SS Kalia","year":"2017","unstructured":"Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): A policy statement of the American college of medical genetics and genomics. Genet Med. 2017;19:249\u201355. https:\/\/doi.org\/10.1038\/gim.2016.190.","journal-title":"Genet Med"},{"key":"1404_CR16","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","volume":"23","author":"DT Miller","year":"2021","unstructured":"Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American college of medical genetics and genomics (ACMG). Genet Med. 2021;23:1381\u201390. https:\/\/doi.org\/10.1038\/s41436-021-01172-3.","journal-title":"Genet Med"},{"key":"1404_CR17","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304:967\u201375. https:\/\/doi.org\/10.1001\/jama.2010.1237.","journal-title":"JAMA"},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ijc.29032","volume":"136","author":"BA Heemskerk-Gerritsen","year":"2015","unstructured":"Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM, Ausems MG, Coll\u00e9e JM, Jansen L, et al. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1\/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer. 2015;136:668\u201377. https:\/\/doi.org\/10.1002\/ijc.29032.","journal-title":"Int J Cancer"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"CD012464","DOI":"10.1002\/14651858.CD012464.pub2","volume":"8","author":"GU Eleje","year":"2018","unstructured":"Eleje GU, Eke AC, Ezebialu IU, Ikechebelu JI, Ugwu EO, Okonkwo OO. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. Cochrane Database Syst Rev. 2018;8:CD012464. https:\/\/doi.org\/10.1002\/14651858.CD012464.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1404_CR20","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/j.clbc.2018.09.011","volume":"19","author":"YL Xiao","year":"2019","unstructured":"Xiao YL, Wang K, Liu Q, Li J, Zhang X, Li HY. Risk reduction and survival benefit of risk-reducing salpingo-oophorectomy in hereditary breast cancer: meta-analysis and systematic review. Clin Breast Cancer. 2019;19:e48\u201365. https:\/\/doi.org\/10.1016\/j.clbc.2018.09.011.","journal-title":"Clin Breast Cancer"},{"key":"1404_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.2140","volume":"1","author":"K Manickam","year":"2018","unstructured":"Manickam K, Buchanan AH, Schwartz MLB, Hallquist MLG, Williams JL, Rahm AK, et al. Exome sequencing-based screening for BRCA1\/2 expected pathogenic variants among adult biobank participants. JAMA Netw Open. 2018;1: e182140. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.2140.","journal-title":"JAMA Netw Open"},{"key":"1404_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13073-019-0691-1","volume":"12","author":"NS Abul-Husn","year":"2019","unstructured":"Abul-Husn NS, Soper ER, Odgis JA, Cullina S, Bobo D, Moscati A, et al. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank. Genome Med. 2019;12:2. https:\/\/doi.org\/10.1186\/s13073-019-0691-1.","journal-title":"Genome Med"},{"key":"1404_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236907","volume":"16","author":"H Tokunaga","year":"2021","unstructured":"Tokunaga H, Iida K, Hozawa A, Ogishima S, Watanabe Y, Shigeta S, et al. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3552 Japanese whole genomes (3.5KJPNv2). PLoS ONE. 2021;16: e0236907. https:\/\/doi.org\/10.1371\/journal.pone.0236907.","journal-title":"PLoS ONE"},{"key":"1404_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2188\/jea.JE20150268","volume":"26","author":"S Kuriyama","year":"2016","unstructured":"Kuriyama S, Yaegashi N, Nagami F, Arai T, Kawaguchi Y, Osumi N, et al. The Tohoku medical megabank project: design and mission. J Epidemiol. 2016;26:493\u2013511. https:\/\/doi.org\/10.2188\/jea.JE20150268.","journal-title":"J Epidemiol"},{"key":"1404_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2188\/jea.JE20190271","volume":"31","author":"A Hozawa","year":"2021","unstructured":"Hozawa A, Tanno K, Nakaya N, Nakamura T, Tsuchiya N, Hirata T, et al. Study profile of the Tohoku medical megabank community-based cohort study. J Epidemiol. 2021;31:65\u201376. https:\/\/doi.org\/10.2188\/jea.JE20190271.","journal-title":"J Epidemiol"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ije\/dyz169","volume":"49","author":"S Kuriyama","year":"2020","unstructured":"Kuriyama S, Metoki H, Kikuya M, Obara T, Ishikuro M, Yamanaka C, et al. Cohort profile: Tohoku medical megabank project birth and three-generation cohort study (TMM BirThree cohort study): rationale, progress and perspective. Int J Epidemiol. 2020;49:18\u201319m. https:\/\/doi.org\/10.1093\/ije\/dyz169.","journal-title":"Int J Epidemiol"},{"key":"1404_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.31662\/jmaj.2019-0014","volume":"2","author":"N Fuse","year":"2019","unstructured":"Fuse N, Sakurai-Yageta M, Katsuoka F, Danjoh I, Shimizu R, Tamiya G, et al. Establishment of integrated biobank for precision medicine and personalized healthcare: the Tohoku medical megabank project. JMA J. 2019;2:113\u201322. https:\/\/doi.org\/10.31662\/jmaj.2019-0014.","journal-title":"JMA J."},{"key":"1404_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1620\/tjem.248.45","volume":"248","author":"N Minegishi","year":"2019","unstructured":"Minegishi N, Nishijima I, Nobukuni T, Kudo H, Ishida N, Terakawa T, et al. Biobank establishment and sample management in the Tohoku medical megabank project. Tohoku J Exp Med. 2019;248:45\u201355. https:\/\/doi.org\/10.1620\/tjem.248.45.","journal-title":"Tohoku J Exp Med"},{"key":"1404_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41439-021-00175-5","volume":"8","author":"S Ogishima","year":"2021","unstructured":"Ogishima S, Nagaie S, Mizuno S, Ishiwata R, Iida K, Shimokawa K, et al. dbTMM: an integrated database of large-scale cohort, genome and clinical data for the Tohoku medical megabank project. Hum Genome Var. 2021;8:44. https:\/\/doi.org\/10.1038\/s41439-021-00175-5.","journal-title":"Hum Genome Var"},{"key":"1404_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s10038-021-00952-8","volume":"67","author":"H Kawame","year":"2022","unstructured":"Kawame H, Fukushima A, Fuse N, Nagami F, Suzuki Y, Sakurai-Yageta M, et al. The return of individual genomic results to research participants: design and pilot study of Tohoku medical megabank project. J Hum Genet. 2022;67:9\u201317. https:\/\/doi.org\/10.1038\/s10038-021-00952-8.","journal-title":"J Hum Genet"},{"key":"1404_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.31662\/jmaj.2021-0156","volume":"5","author":"K Ohneda","year":"2022","unstructured":"Ohneda K, Hiratsuka M, Kawame H, Nagami F, Suzuki Y, Suzuki K, et al. A pilot study for return of individual pharmacogenomic results to population-based cohort study participants. JMA J. 2022;5:177\u201389. https:\/\/doi.org\/10.31662\/jmaj.2021-0156.","journal-title":"JMA J"},{"key":"1404_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1017\/s0033291702006074","volume":"32","author":"RC Kessler","year":"2002","unstructured":"Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SL, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959\u201376. https:\/\/doi.org\/10.1017\/s0033291702006074.","journal-title":"Psychol Med"},{"issue":"1","key":"1404_CR33","first-page":"913","volume":"37","author":"K Yokoyama","year":"1990","unstructured":"Yokoyama K, Araki S, Kawakami N, Takeshita T. Production of the Japanese edition of profile of mood states (POMS): assessment of reliability and validity. Nihon Koshu Eisei Zasshi. 1990;37(1):913\u20138.","journal-title":"Nihon Koshu Eisei Zasshi"},{"key":"1404_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00005053-200203000-00006","volume":"190","author":"N Asukai","year":"2002","unstructured":"Asukai N, Kato H, Kawamura N, Kim Y, Yamamoto K, Kishimoto J, et al. Reliability and validity of the Japanese-language version of the impact of event scale-revised (IES-R-J): four studies of different traumatic events. J Nerv Ment Dis. 2002;190:175\u201382. https:\/\/doi.org\/10.1097\/00005053-200203000-00006.","journal-title":"J Nerv Ment Dis"},{"key":"1404_CR35","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1038\/ncomms9018","volume":"6","author":"M Nagasaki","year":"2015","unstructured":"Nagasaki M, Yasuda J, Katsuoka F, Nariai N, Kojima K, Kawai Y, et al. Rare variant discovery by deep whole-genome sequencing of 1070 Japanese individuals. Nat Commun. 2015;6:8018. https:\/\/doi.org\/10.1038\/ncomms9018.","journal-title":"Nat Commun"},{"key":"1404_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41439-019-0059-5","volume":"6","author":"S Tadaka","year":"2019","unstructured":"Tadaka S, Katsuoka F, Ueki M, Kojima K, Makino S, Saito S, et al. 3.5KJPNv2: An allele frequency panel of 3552 Japanese individuals including the X chromosome. Hum Genome Var. 2019;6:28. https:\/\/doi.org\/10.1038\/s41439-019-0059-5.","journal-title":"Hum Genome Var"},{"key":"1404_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"1404_CR38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jama.2021.23686","volume":"327","author":"IS Forrest","year":"2022","unstructured":"Forrest IS, Chaudhary K, Vy HMT, Petrazzini BO, Bafna S, Jordan DM, et al. Population-based penetrance of deleterious clinical variants. JAMA. 2022;327:350\u20139. https:\/\/doi.org\/10.1001\/jama.2021.23686.","journal-title":"JAMA"},{"key":"1404_CR39","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41436-020-0862-x","volume":"22","author":"DR Barnes","year":"2020","unstructured":"Barnes DR, Rookus MA, McGuffog L, Leslie G, Mooij TM, Dennis J, et al. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genet Med. 2020;22:1653\u201366. https:\/\/doi.org\/10.1038\/s41436-020-0862-x.","journal-title":"Genet Med"},{"key":"1404_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jb\/mvab060","volume":"170","author":"M Sakurai-Yageta","year":"2021","unstructured":"Sakurai-Yageta M, Kumada K, Gocho C, Makino S, Uruno A, Tadaka S, et al. Japonica Array NEO with increased genome-wide coverage and abundant disease risk SNPs. J Biochem. 2021;170:399\u2013410. https:\/\/doi.org\/10.1093\/jb\/mvab060.","journal-title":"J Biochem"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-022-01404-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:13:26Z","timestamp":1672841606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-022-01404-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1007\/s12282-022-01404-7","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}